NPR  Aug 22  Comment 
Lots of people forget to take their medicine on time. Now firms are selling "smart" pill bottles that send patients reminders through the Internet. But maybe the real problem isn't forgetfulness.
GenEng News  Aug 21  Comment 
The FDA has approved the first fixed-dose combination treatment designed to address in a single pill both causes of hyperuricemia in gout—overproduction and underexcretion of serum uric acid. Ironwood Pharmaceuticals will market Duzallo ®...
FierceBiotech  Aug 17  Comment 
In this week's EuroBiotech Report, Vicarius raises $22 million, GlaxoSmithKline jilts Ionis, CellAct lands a $250 million deal and more. 
FierceBiotech  Aug 15  Comment 
Lexicon Pharmaceuticals has bolstered the case for its Sanofi-partnered diabetes pill. The latest update means Lexicon now has data from two phase 3 trials showing the effect of the SGLT1-SGLT2 inhibitor sotagliflozin on A1C in patients with Type...
MedPage Today  Aug 11  Comment 
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff
New York Times  Aug 10  Comment 
Through two women’s stories of unplanned pregnancy, we look at an unproven treatment to stop a medication abortion after it’s begun.
The Economic Times  Aug 9  Comment 
In an interview with ET, HP's CEO Dion Weisler spoke about the company’s plans for India-specific devices and its prospects in the Indian market.
BBC News  Aug 6  Comment 
Elina Berglund Scherwitzl has created an app that offers women a "natural alternative" to the pill
New York Times  Aug 4  Comment 
The brash Mr. Shkreli, best known for increasing the price of a drug to $750 from $13.50 a pill overnight, was convicted by a federal jury in Brooklyn.
The Economic Times  Aug 4  Comment 
While life-saving medicines imported for personal use would continue to be exempt from basic customs duty, they are not exempt from IGST.


Related Articles



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki